Navigation Links
Daiichi Sankyo Launches LIXIANA® (edoxaban), a Direct Oral Factor Xa Inhibitor, in Japan for the Prevention of Venous Thromboembolism after Major Orthopedic Surgery
Date:7/19/2011

l respond to market and customer diversity and optimize growth opportunities across the value chain. For more information, please visit www.daiichisankyo.com.

References

  1. http://www.pmda.go.jp/operations/shonin/info/new/file/H23Pharmaceutical.pdf
  2. T. Fuji et al., Edoxaban versus enoxaparin for thromboprophylaxis after total knee replacement: The STARS E-3 trial 21st International Congress of Thrombosis, July 6 – 9 2010, Milano.
  3. T. Fuji et al., Efficacy and Safety of Edoxaban Versus Enoxaparin for the Prevention of Venous Thromboembolism Following Total Hip Arthroplasty: STARS J-V trial, December 4-7 2010, Orlando, Florida.
  4. Clinicaltrials.gov: NCT00781391. Last accessed July 2011. Available at: http://clinicaltrials.gov/ct2/show/NCT00781391?term=ENGAGE++AF-TIMI+48&rank=1
  5. Clinicaltrials.gov: NCT00986154. Last accessed: July 2011. Available at http://www.clinicaltrials.gov/ct2/show/NCT00986154?term=hokusai&rank=1

For more information, please contact:Toshiaki Sai

Daiichi Sankyo, Co., Ltd. (Japan)

+81-3-6225-1126 (office)

Alyssa Dargento

Daiichi Sankyo, Inc. (US)

(973) 944-2913 (office)

(973) 727-1464 (mobile)Dr. Michaela Paudler-Debus

Daiichi Sankyo Europe GmbH

+49 (0)89-78 08 685 (office)

+49 (0)172-845 8974 (mobile)Forward-looking statementsThis press release contains forward-looking statements and information about future developments in the sector, and the legal and business conditions of DAIICHI SANKYO, Co. Ltd, DAIICHI SANKYO, Inc., and DAIICHI SANKYO EUROPE
'/>"/>

SOURCE Daiichi Sankyo
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Daiichi Sankyo and Forest Laboratories Finalize Contract for Co-Promotion of AZOR(TM)
2. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
3. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
4. FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel
5. Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b
6. Daiichi Sankyo and Lilly Respond to Speculation on Status of Prasugrel New Drug Application
7. Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation
8. Daiichi Sankyo Initiates Largest Single, Double-Blind, Randomized, Phase III Trial for Treatment and Prevention of Recurrent Venous Thromboembolism
9. Daiichi Sankyo Co, Ltd. Joins the National Cherry Blossom Festival in Washington D.C. as Centennial Celebration Committee Co-Chair
10. Daiichi Sankyo/Lilly Respond to ACCF/AHA Clinical Alert on Antiplatelet Therapy
11. Accumetrics, Inc., Daiichi Sankyo, Inc. and Eli Lilly and Company Launch Strategic U.S. Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... CITY, Calif. , Nov. 26, 2014  Genomic ... Kim Popovits , Chairman, Chief Executive Officer and ... Piper Jaffray Healthcare Conference at The New York Palace ... Wednesday, December 3 at 11:30 am Eastern Time (ET). ... webcast of the conference call, go to the  Investor ...
(Date:11/26/2014)... Nov. 26, 2014  Avanir Pharmaceuticals, Inc. (NASDAQ: ... Food and Drug Administration (FDA) has issued a ... (NDA) for AVP-825. AVP-825 is an investigational drug-device ... intranasally utilizing a novel Breath Powered delivery technology. ... and consistent with the preliminary feedback announced on ...
(Date:11/26/2014)... 2014 Scott Steiger lives in ... As an engineer for the past 20 years, he,s traveled extensively ... service. He,s been to six of the seven continents. Travel is ... http://photos.prnewswire.com/prnh/20141126/161076 Photo - http://photos.prnewswire.com/prnh/20141126/161077 ... a pretty good idea of what,s required. His latest ...
Breaking Medicine Technology:Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 2Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 3Avanir Pharmaceuticals Receives Complete Response Letter (CRL) from FDA on AVP-825 NDA 4Steiger Has Created the First Pill Case Specifically Designed For Travel 2
(Date:11/29/2014)... 29, 2014 Syntermed, Inc. announces availability ... product for the U.S. nuclear medicine market ... Chicago, IL. , “NeuroQ is well established ... the quantitation of PET- FDG and Amyloid brain ... step,” announced Michael Lee, CEO, Syntermed, Inc. “Radiologists and ...
(Date:11/28/2014)... (PRWEB) November 29, 2014 North America ... by Europe. The U.S. market is highly supported by ... researches in different clinical institutes such as National Cancer ... the Asia-Pacific region is expected to show a remarkable ... of the World are poised to grow at a ...
(Date:11/28/2014)... Lunadress.co.uk, one of the world’s leading suppliers ... released its fashionable white prom gowns. These new ... low price. The company provides a big discount of ... shipping for orders over 99 pounds. , LunaDress provides ... representatives if needed. The kind experts will explain the ...
(Date:11/28/2014)... Tbdress.com has recently announced ... online on Nov. 28, 2014. The special offer will ... many more) at greatly discounted prices. , The ... cultural holiday, celebrated generally on December 25 by billions ... Christmas sales, are always provided in December.” , ...
(Date:11/28/2014)... sells cheap tall cocktail dresses worldwide and ... there is a new collection of tall cocktail dresses ... at very low prices. It is really worthy to ... by UWDress.com , UWDress.com is one of the most ... has the power to ensure customer satisfaction. Now, the ...
Breaking Medicine News(10 mins):Health News:Syntermed's NeuroQ™ 3.7 for SPECT Brain Imaging Announced at RSNA 2Health News:Syntermed's NeuroQ™ 3.7 for SPECT Brain Imaging Announced at RSNA 3Health News:Researchmoz : Global Radiopharmaceuticals/Nuclear Medicine Market Analysis - Trends & Forecast to 2020 2Health News:Researchmoz : Global Radiopharmaceuticals/Nuclear Medicine Market Analysis - Trends & Forecast to 2020 3Health News:LunaDress.co.uk: New White LunaDress Prom Gowns Online for Sale Now 2Health News:Tbdress.com Announced Its Christmas Eve Sales 2Health News:Graceful Tall Cocktail Dresses With New Features Just Added To UWDress.com 2
... achieved such a central place in public consciousness as ... it is a feared weapon of bioterrorism Bacillus anthracis ... research of the celebrated 19th century scientists Robert Koch ... diseases and immunology In his new book Bacillus ...
... are reporting the development of a new, ultra-light form ... solid material with amazing strength and an incredibly ... (MCNT) aerogel" could be used in sensors to detect ... A report about the material appears in ACS ...
... more persistent memory of fear conditioning - acquired by ... and lack the ability to inhibit this fear. This ... from Post-Traumatic Stress Disorder (PTSD), an anxiety disorder which ... as a violent attack, a natural disaster or physical ...
... kilos you,ve put on over Christmas, you may be interested in ... in your likelihood of regaining weight after dieting. A new study ... levels of ghrelin are more likely to put the centimetres they ... patients who, after sticking to a slimming diet, have regained the ...
... vital tumor-suppressing mechanism that is often broken in malignant ... goes haywire to stimulate cancer growth have earned two ... Center membership in a distinguished association of scholars. ... and chair of MD Anderson,s Department of Molecular and ...
... By Steven Reinberg HealthDay Reporter , TUESDAY, Jan. ... heart failure patients taking the blood pressure drug candesartan stood ... Swedish researchers report. In fact, 61 percent of those ... taking losartan (Cozaar); this difference may be due to differences ...
Cached Medicine News:Health News:'Bacillus anthracis and Anthrax' 2Health News:Drug reduces the increase in fear caused by previous traumatic experiences in mice 2Health News:'Yo-yo' effect of slimming diets explained 2Health News:Peers elect MD Anderson's Hung and Lozano as Fellows of AAAS 2Health News:Peers elect MD Anderson's Hung and Lozano as Fellows of AAAS 3Health News:Not All Heart Failure Drugs Boost Survival Equally 2
... Korchek Technologies CareChek Tx, ... as a software device for ... to match the patient to ... the bedside before administering a ...
... 140XiIII is the fastest barcoding printer ... such powerful performance and steel construction, ... high-volume, mission-critical applications with 24-hour duty ... for applications in which labels are ...
... you use technology that improves patient outcomes. ... simple-to-use BD.id Patient Identification System for Specimen ... the specimen container, and the order of ... only for specimens actually collected, with both ...
... ID verification and laboratory specimen labeling system uses ... phlebotomist or nurse, the identity of the patient ... is made, a bar coded sample ID label ... design simplifies and eliminates the interface problems inherent ...
Medicine Products: